Abingdon Health (LSE:ABDX) Insider Ownership : 16.63 % (As of Jun. 07, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abingdon Health's insider ownership is 16.63%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abingdon Health's Institutional Ownership is 1.52%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abingdon Health's Float Percentage Of Total Shares Outstanding is 0.00%.

Abingdon Health Insider Ownership Historical Data

The historical data trend for Abingdon Health's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Insider Ownership Chart

Abingdon Health Historical Data

The historical data trend for Abingdon Health can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Insider Ownership	14.72	14.72	17.31	17.31	17.31	17.31	17.31	17.31	17.31	16.63

Abingdon Health Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines